Embree Financial Group Reduces Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Embree Financial Group decreased its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 24.0% during the second quarter, HoldingsChannel.com reports. The fund owned 466 shares of the healthcare conglomerate’s stock after selling 147 shares during the period. Embree Financial Group’s holdings in UnitedHealth Group were worth $238,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. International Assets Investment Management LLC increased its position in UnitedHealth Group by 1.9% during the 4th quarter. International Assets Investment Management LLC now owns 4,468 shares of the healthcare conglomerate’s stock worth $2,352,000 after bought another 85 shares during the period. Aveo Capital Partners LLC boosted its holdings in UnitedHealth Group by 23.8% in the 4th quarter. Aveo Capital Partners LLC now owns 2,164 shares of the medical conglomerate’s stock worth $1,139,000 after buying an additional 416 shares during the last quarter. 9258 Wealth Management LLC raised its stake in UnitedHealth Group by 7.3% during the 4th quarter. 9258 Wealth Management LLC now owns 4,273 shares of the healthcare conglomerate’s stock worth $2,250,000 after buying another 290 shares in the last quarter. Wealthcare Advisory Partners LLC boosted its stake in UnitedHealth Group by 59.9% in the 4th quarter. Wealthcare Advisory Partners LLC now owns 5,186 shares of the healthcare conglomerate’s stock worth $2,730,000 after buying another 1,942 shares in the last quarter. Finally, Lincoln National Corp boosted its stake in UnitedHealth Group by 7.7% in the fourth quarter. Lincoln National Corp now owns 15,489 shares of the healthcare conglomerate’s stock worth $8,154,000 after acquiring an additional 1,107 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s shares.

Indoor activity

In other news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available via this link. In related news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available on the SEC’s website. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s shares.

UnitedHealth Group’s stock performance

Shares of UNH stock opened at $590.20 on Tuesday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $593.26. The company has a market cap of $545.00 billion, a P/E ratio of 36.08, a PEG ratio of 1.64 and a beta of 0.58. The company has a current ratio of 0.88, a quick ratio of 0.88, and a debt-to-equity ratio of 0.67. The firm has a fifty day moving average price of $550.35 and a 200 day moving average price of $512.88.

UnitedHealth Group (NYSE:UNH – Get Free Report ) last announced its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. In the same period last year, the company earned $6.14 per share. UnitedHealth Group’s quarterly revenue was up 6.4% compared to the same quarter last year. sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.67 earnings per share for the current fiscal year.

UnitedHealth Group announces dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16. This represents a dividend of $8.40 on an annualized basis and a dividend yield of 1.42%. UnitedHealth Group’s payout ratio is 51.34%.

Analysts set new price targets

Several analysts have recently commented on the stock. Truist Financial raised their target price on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and upped their target price for the company from $481.00 to $647.00 in a report on Wednesday, July 17th . UBS Group lifted their target price on shares of UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a report on Thursday, July 18th. Wells Fargo & Company raised their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Finally, Argus boosted their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $614.17.

Check out our latest report on UNH

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. The UnitedHealthcare segment provides consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses and individuals; health care coverage and health and wellness services for people age 50 and older that address their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits and hospital and clinic services, and health care products and services for state care programs for the economically disadvantaged, medically underserved, and those without funded health care coverage by employer.

See Also

Want to see what other hedge funds own UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Get daily news and ratings for UnitedHealth Group – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.